Association of COX2 −765G>C promoter polymorphism and coronary artery disease in Korean population

[1] Adderley SR(1999)Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2 J Biol Chem 274 5038-5046

[2] Fitzgerald DJ(1994)Inflammation and coronary artery disease N Engl J Med 331 468-469

[3] Alexander RW(1999)Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages Arterioscler Thromb Vasc Biol 19 646-655

[4] Baker CS(2000)Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis Circulation 102 840-845

[5] Hall RJ(2005)Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice J Mol Cell Cardiol 39 443-452

[6] Evans TJ(2007)COX2 genetic variation, NSAIDs, and advanced prostate cancer risk Br J Cancer 97 557-561

[7] Pomerance A(2008)Up-regulation of inflammatory signalings by areca nut extract and role of cyclooxygenase-2 -1195G > a polymorphism reveal risk of oral cancer Cancer Res 68 8489-8498

[8] Maclouf J(2001)Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability Circulation 104 921-927

[9] Creminon C(2003)Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans Circulation 107 1479-1485

[10] Yacoub MH(2004)A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke JAMA 291 2221-2228

[1] Adderley SR(1999)Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2 J Biol Chem 274 5038-5046

[2] Fitzgerald DJ(1994)Inflammation and coronary artery disease N Engl J Med 331 468-469

[3] Alexander RW(1999)Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages Arterioscler Thromb Vasc Biol 19 646-655

[4] Baker CS(2000)Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis Circulation 102 840-845

[5] Hall RJ(2005)Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice J Mol Cell Cardiol 39 443-452

[6] Evans TJ(2007)COX2 genetic variation, NSAIDs, and advanced prostate cancer risk Br J Cancer 97 557-561

[7] Pomerance A(2008)Up-regulation of inflammatory signalings by areca nut extract and role of cyclooxygenase-2 -1195G > a polymorphism reveal risk of oral cancer Cancer Res 68 8489-8498

[8] Maclouf J(2001)Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability Circulation 104 921-927

[9] Creminon C(2003)Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans Circulation 107 1479-1485

[10] Yacoub MH(2004)A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke JAMA 291 2221-2228